Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bludigo in ureteral patency assessment
NCT06054880Phase 4Recruiting
- Sponsor
- Provepharma
- Start
- Oct 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indigotindisulfonate sodium, sponsored by Provepharma. Started Oct 2023; status: recruiting.
02
Drugs
indigotindisulfonate sodium
Beyond the preview
Go deeper on NCT06054880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06054880.